BMS Mumbai
Bristol Myers Squibb commercial operations
BMS is among the world's leading biopharmaceutical companies. The company is dedicated to discovering, developing and delivering innovative medicines for patients with serious diseases.
Our objective is to extend patients' lives and enhance their overall well-being by accelerating the introduction of innovative therapies and broadening patient access in key focus areas such as oncology, hematology, immunology, neuroscience and cardiovascular health.
As part of global operations, Bristol Myers Squibb India Pvt Ltd was incorporated in June 2004 and is the Indian subsidiary of Bristol-Myers Squibb Company. Headquartered in Mumbai, BMS India offers innovative treatment solutions in Oncology and Hematology.
We believe in the value our medicines bring to patients and society, and their role in transforming care to help patients live longer and healthier lives. We are committed to helping patients gain access to our medicines while addressing inequities and barriers to high-quality, affordable healthcare.
.jpeg "Our medicines")
We endeavor to improve patient access and continue to support patients in India through our patient support programs, enabling them to benefit from innovative medicines. Over 30000 patients have benefitted through our Patient support programs in India. The company presently offers patient support programs for treatments in oncology and hematology. We believe that patients can only benefit from our medicines if they are able to access them. We at BMS are committed to bringing more innovative medicines to more patients in India, faster.
Patients / Caregivers can avail more information about our programs SAMBHAV (Oncology) and AARAMBH (Hematology) through their treating healthcare practitioners.
For SAMBHAV :
Basis the valid prescription from the treating Oncologist for Opdyta, Patient / Caretaker can call on 18002671982 or email their details on opdytacare opdytacare@oasiscenter.co.in
For AARAMBH :
Basis the valid prescription from the treating Hematologist for Rojuzda, Patient / Caretaker can call on 18002098860 or email their details on Aarambh Aarambh@oasiscenter.co.in
*Disclaimer : Patient Support Program is applicable to eligible patients who are prescribed Luspatercept [Rojuzda]® / Nivolumab (Opdyta) as per the DCGI (Drugs Controlled General of India) approved indications in India and do not have full reimbursement. Enrollment to Patient Support Program is subject to the terms & conditions and provided Patient gets required medical benefits due to OPDYTA® / Rojuzda
Statutory requirements
for Bristol Myers Squibb India Pvt Ltd
Find out more about BMS research and development
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.
NO-IN-2400012
Expiry: 14 Nov. 2026